📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
35 announcements match the current filters (relevance ≥ 5).
Capillary Technologies Secures $20 Million 5-Year Deal with US Fortune 50 Retailer
Capillary Technologies has signed a strategic five-year agreement with a Fortune 50 US retailer, with a total contract value exceeding $20 million. The company will implement its AI-powered Loyalty+ and aiRA platforms to modernize the retailer's customer engagement and loyalty ecosystem. This deal provides significant long-term revenue visibility and validates Capillary's competitive positioning in the high-value US retail market. The partnership focuses on delivering hyper-personalized experiences and real-time data intelligence at a massive scale.
Key Highlights
Total contract value (TCV) of more than $20 million over a five-year duration.
Strategic partnership with a Fortune 50 company and one of the largest retailers in the United States.
Implementation of AI-driven platforms including Loyalty+ and aiRA for offer optimization.
Focus on real-time customer intelligence and hyper-personalization across a national retail footprint.
👀 What to Watch
This is a significant win that demonstrates Capillary's ability to compete for large-scale global contracts. Investors should monitor the company's ability to leverage this high-profile client to win further business in the North American SaaS market.
Capillary Technologies Clarifies ESOP 2021 Price; Caps Discount at 20% of 90-Day VWAP
Capillary Technologies has issued a clarification regarding its ESOP 2021 scheme following feedback from proxy advisors. The company has specified that the exercise price for options granted post-listing will be subject to a maximum discount of 20% to the 90-day Volume Weighted Average Price (VWAP). This clarification aims to address concerns regarding arbitrary pricing and ensures that the scheme is market-linked. The resolution under discussion involves extending these ESOP benefits to employees of both Indian and overseas subsidiaries.
Key Highlights
Exercise price for ESOP 2021 grants capped at a maximum 20% discount to the 90-day VWAP.
The 90-day VWAP will be calculated based on the stock exchange with the highest trading volume.
Minimum exercise price for options is set at the face value of INR 2 per share.
Clarification follows feedback from proxy advisors regarding lack of transparency in the original Postal Ballot Notice.
The scheme covers employees of subsidiary companies across both domestic and international jurisdictions.
👀 What to Watch
Investors should note the improved transparency in the ESOP pricing mechanism which limits potential deep-discount dilution. No immediate action is required as this is a governance-related clarification.
Capillary Technologies to Host Investor Call on Acquisition of SessionM from Mastercard
Capillary Technologies India Limited has scheduled an analyst and investor call for February 27, 2026, at 10:00 A.M. IST. The primary agenda is to provide a corporate update regarding the acquisition of SessionM from Mastercard. This strategic move is expected to enhance Capillary's loyalty and customer engagement offerings globally. Investors should focus on the deal valuation, integration timeline, and projected impact on the company's bottom line.
Key Highlights
Investor and analyst call scheduled for February 27, 2026, at 10:00 A.M. IST
The call focuses on the strategic acquisition of SessionM from Mastercard
Official intimation filed under Regulation 30 of SEBI Listing Regulations on February 24, 2026
Sunil Jain, Head of Corporate Development, named as the primary contact for investor queries
👀 What to Watch
Investors should attend or review the transcript of the February 27 call to understand the financial implications and synergies of the SessionM acquisition. Monitor the stock for potential re-rating based on the scale of this global expansion.
Capillary Technologies to Acquire Session M for $20M, Boosting ARR to $115M+
Capillary Technologies has announced the acquisition of Session M Inc. from Mastercard for a base consideration of $20M. This strategic move adds approximately $35M in Annual Recurring Revenue (ARR), bringing the company's total combined ARR to over $115M. The acquisition provides access to 40+ enterprise customers, including 5 Fortune 500 brands across the QSR, airline, and retail sectors. Capillary expects to achieve EBITDA profitability for Session M within the first year and aims for a total company adjusted EBITDA of ₹398 Cr by FY30.
Key Highlights
Acquisition of Session M for $20M base consideration to add $35M+ in Continued ARR
Combined entity will serve 150+ customers, including 25 Fortune 500 companies globally
Integration of 60 customers from Kognitiv and Session M acquisitions planned over 24-36 months
Projected FY30 Adjusted EBITDA of ₹398 Cr with a target of 45%+ Free Cash Flow post-integration
Strategic expansion into North America (70% of Session M revenue) and new entry into LATAM markets
👀 What to Watch
Investors should monitor the integration of Session M, which is acquired at a highly attractive revenue multiple, as it significantly scales Capillary's US footprint. The key performance indicator will be the company's ability to transition acquired customers to its platform to boost gross margins from 30% to 65%.
Capillary Technologies Acquires SessionM from Mastercard to Bolster Global Loyalty Leadership
Capillary Technologies has entered into a definitive agreement to acquire SessionM, a customer engagement and loyalty company, from Mastercard. This acquisition follows the company's November 2025 IPO and previous integrations of Brierley and Kognitiv, reinforcing its inorganic growth strategy. SessionM brings a high-profile global customer base, including Fortune 500 retailers and airlines, which will now be integrated into Capillary's AI-native loyalty platform. The company currently serves 115 customers across 47 countries, and this deal is expected to significantly expand its enterprise footprint.
Key Highlights
Strategic acquisition of SessionM from Mastercard to enhance AI-powered loyalty and engagement solutions.
SessionM's portfolio includes Fortune 500 retailers, airlines, and CPG brands, expanding Capillary's global reach.
Follows the company's successful listing on Indian Stock Exchanges in November 2025 and previous acquisitions of Brierley and Kognitiv.
Capillary currently serves 115 customers, including 20 Fortune 500 companies, across 47 countries.
Specialized technical team from SessionM will transition to Capillary to ensure continuity and expertise preservation.
👀 What to Watch
Investors should view this as a positive execution of the company's post-IPO growth strategy. Monitor the integration efficiency and the impact of this acquisition on the company's consolidated revenue and margins in the coming quarters.
Capillary Technologies to Host Call on Acquisition of SessionM from Mastercard
Capillary Technologies India Limited has scheduled an investor and analyst call for February 27, 2026, at 10:00 A.M. IST. The primary agenda for the call is to provide a corporate update regarding the acquisition of SessionM from Mastercard. This strategic move is expected to enhance the company's customer engagement and loyalty platform capabilities. Investors should focus on the financial terms of the deal and the projected impact on global revenue growth.
Key Highlights
Investor and analyst call scheduled for February 27, 2026, to discuss corporate updates.
The call specifically addresses the acquisition of SessionM from Mastercard.
Intimation filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Sunil Jain, Head of Corporate Development, named as the primary contact for investor queries.
👀 What to Watch
Investors should attend or review the transcript of the February 27 call to understand the acquisition's valuation and synergy potential. Monitor for details on how this integration will affect the company's EBITDA margins and international expansion strategy.
Capillary Technologies to Acquire Mastercard's Session M Inc. for USD 20 Million
Capillary Technologies has approved the 100% acquisition of Session M Inc., a US-based loyalty SaaS platform, from Mastercard Inc. for a base cash consideration of USD 20 million. Session M reported a turnover of USD 50.5 million in CY2025, suggesting the acquisition is being made at a highly attractive valuation of approximately 0.4x price-to-sales. The deal aims to significantly expand Capillary's presence in North America and LATAM while adding a blue-chip clientele across retail and aviation sectors. The transaction is expected to be completed within 180 days.
Key Highlights
Acquisition of 100% stake in Session M Inc. and its Czech subsidiary for USD 20 million base consideration.
Target company generated USD 50.5 million revenue in CY2025, though revenue has trended down from USD 57 million in CY2023.
Strategic expansion into North American, LATAM, and APAC loyalty software markets.
Acquisition includes a portfolio of blue-chip clients in Food & Beverage, Retail, and Airlines.
The transaction is an all-cash deal expected to close within approximately 6 months.
👀 What to Watch
Investors should monitor the integration of this high-revenue asset, as the low acquisition multiple could significantly boost Capillary's valuation if margins are maintained. Watch for updates on how this acquisition impacts the company's consolidated profitability in the coming quarters.
Capillary Technologies Q3 FY26: 22% Revenue Growth and INR 66 Cr New Order Book
Capillary Technologies reported a strong performance for the first nine months of FY26, with revenue growing at 22% while non-COGS costs increased by only 11%, demonstrating significant operating leverage. The company achieved an overall Net Retention Rate (NRR) of 111%, with organic NRR reaching 115%, driven by platform upgrades and global expansions. New order book wins totaled INR 66 crores for the nine-month period, compared to INR 53 crores in the previous year. Management continues to execute its M&A strategy, recently acquiring Kognitiv and sunsetting legacy platforms to improve gross margins, which rose by 1.5% during the period.
Key Highlights
Revenue grew by 22% in the first nine months of FY26, significantly outpacing non-COGS cost growth of 11%.
Organic Net Retention Rate (NRR) stood at a robust 115%, highlighting strong expansion within existing enterprise accounts.
New order book reached INR 66 crores for the 9-month period, up from INR 53 crores in the same period last year.
Gross margins improved by 1.5% as the company successfully migrated acquired customers to its core high-margin platform.
Recognized as a leader in the December 2025 Forrester Wave, scoring 5/5 in 22 out of 27 evaluation criteria.
👀 What to Watch
Investors should focus on the company's successful execution of its 'buy and migrate' M&A strategy which is driving margin expansion. The strong organic NRR and top-tier analyst recognition suggest a sustainable competitive advantage in the global loyalty management market.
Capillary Tech seeks nod to extend ESOP 2021 to subsidiary staff; 72.91 lakh shares in pool
Capillary Technologies India Limited has issued a postal ballot notice to ratify the extension of its 'Capillary Employees Stock Option Scheme-2021' to employees of its subsidiaries, both in India and overseas. The resolution seeks approval for a pool of 72,91,000 ESOPs, which are exercisable into an equivalent number of equity shares with a face value of ₹2 each. This move is designed to align the interests of subsidiary employees with the parent company's long-term growth. The e-voting period for shareholders is scheduled from February 11, 2026, to March 12, 2026.
Key Highlights
Ratification of ESOP 2021 extension to employees of all subsidiary companies globally.
Total ESOP pool involves 72,91,000 equity shares of ₹2 face value each.
E-voting window is open from February 11, 2026, to March 12, 2026.
Cut-off date for voting eligibility was fixed as February 06, 2026.
The resolution is proposed as a Special Resolution requiring 75% majority approval.
👀 What to Watch
Investors should monitor the potential equity dilution resulting from the 7.29 million shares and participate in the e-voting process if they are eligible shareholders.
Capillary Q3 FY26: Revenue Up 16% YoY; 9M PAT Surges 692% to ₹90.2 Mn
Capillary Technologies reported a steady 16% YoY revenue growth in Q3 FY26, reaching ₹1,840.4 Mn, while 9M FY26 revenue grew 22% to ₹5,432.5 Mn. Although Q3 PAT declined 30% YoY to ₹79.9 Mn due to acquisition-related amortization and one-time IPO costs, the 9M PAT showed a massive 692% jump to ₹90.2 Mn. The company is seeing strong traction from its Kognitiv acquisition and expansion in the healthcare vertical, which boosted its subscriber base by 50% effective January 2026. Management is focusing on AI-led productivity and customer migration to its core platform to sustain profitable growth.
Key Highlights
9M FY26 Operating Revenue grew 22% YoY to ₹5,432.5 Mn, driven by organic growth and Kognitiv acquisition.
Adjusted EBITDA for 9M FY26 rose 53% YoY to ₹712.0 Mn, reflecting improved operational efficiencies.
9M PAT surged nearly 8x to ₹90.2 Mn compared to ₹11.4 Mn in the previous year.
Q3 PAT fell 30% YoY to ₹79.9 Mn, impacted by ₹62.4 Mn in depreciation/amortization and ₹35.9 Mn in one-time costs.
Subscriber base increased by 50% effective Jan 2026 following successful go-lives in the healthcare vertical.
👀 What to Watch
Investors should look past the Q3 PAT decline as it was driven by non-recurring and non-cash items; the strong 9M growth and 50% subscriber jump indicate robust business momentum. Monitor the integration of acquisitions and the impact of AI-led migrations on future margins.
Capillary Tech Q3 FY26: Revenue Grows 37% YoY to ₹580M; Returns to Profitability Post-IPO
Capillary Technologies reported a strong performance for Q3 FY26, with standalone revenue from operations rising 37.1% YoY to ₹579.80 million. The company achieved a turnaround, posting a net profit of ₹10.52 million compared to a loss of ₹29.35 million in the preceding quarter. This is the first financial report following its November 2025 IPO, which added ₹3,229.08 million in net proceeds to the balance sheet. Results include a ₹16.14 million impact from new labour codes and ₹19.77 million in IPO-related expenses.
Key Highlights
Revenue from operations increased 37.1% YoY to ₹579.80 million in Q3 FY26.
Turned around to a net profit of ₹10.52 million from a loss of ₹29.35 million in Q2 FY26.
EBITDA (Profit before finance costs, depreciation, and tax) rose to ₹128.63 million.
Holds ₹3,228.90 million in unutilized IPO proceeds, currently parked in fixed deposits.
Recognized a one-time financial impact of ₹16.14 million due to the implementation of new Labour Codes.
👀 What to Watch
Investors should view the return to profitability and strong revenue growth as positive signs for this newly listed entity. Monitor how the company utilizes its significant cash reserves of over ₹3,200 million for future expansion.
Capillary Tech Q3 FY26 Revenue Up 16% YoY to ₹1,840 Mn; 9M Adj. EBITDA Surges 53%
Capillary Technologies reported a 22% YoY revenue growth for 9M FY26, reaching ₹5,432.5 Mn, driven by strong organic Net Revenue Retention (NRR) of 115%. Adjusted EBITDA for the nine-month period saw a significant jump of 53% to ₹712 Mn, reflecting operational efficiencies and M&A synergies. The company's Annual Recurring Revenue (ARR) reached ₹7,361 Mn, supported by a portfolio of 20 Fortune 500 customers. Despite strong operating performance, PAT growth was tempered by one-time IPO expenses and high acquisition-related amortization.
Key Highlights
9M FY26 Revenue grew 22% YoY to ₹5,432.5 Mn, while Q3 Revenue rose 16% to ₹1,840.4 Mn.
Adjusted EBITDA for 9M FY26 surged 53% YoY to ₹712 Mn, driven by scale and cost synergies.
Annual Recurring Revenue (ARR) reached ₹7,361 Mn, representing a 21% growth over FY25.
Strong cash generation with 9M Operating Cash Flow of ₹1,009 Mn and a closing cash balance of ₹4,635 Mn.
Organic NRR stands at 115%, successfully offsetting planned churn in the inorganic customer portfolio.
👀 What to Watch
Investors should monitor the successful migration of acquired customers to the core platform, which is expected to double gross margins from 30% to 65%. The strong ARR growth and cash flow generation provide a solid foundation for long-term value creation.
Capillary Technologies Named a Leader in Forrester Wave Loyalty Platforms Q4 2025
Capillary Technologies has been recognized as a 'Leader' in the Forrester Wave: Loyalty Platforms report for Q4 2025. This prestigious industry recognition by a global research firm validates the company's technological capabilities and market position in the loyalty management space. Such accolades often serve as a significant catalyst for brand credibility and can assist in securing high-value enterprise contracts globally. The announcement reflects the company's competitive edge and product-market fit in the evolving SaaS landscape.
Key Highlights
Named as a 'Leader' in the Forrester Wave: Loyalty Platforms, Q4 2025 report.
Recognition highlights the company's strong product strategy and execution in the global loyalty tech sector.
Disclosure made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The report is a key benchmark used by global enterprises for vendor selection in the loyalty platform market.
👀 What to Watch
Investors should view this as a positive qualitative indicator of the company's market leadership. Monitor if this recognition leads to increased order inflows or improved revenue growth in the upcoming quarters.
Capillary Technologies to Ratify ESOP 2021 Scheme for 72.91 Lakh Options
Capillary Technologies has issued a postal ballot notice to ratify its existing 'Capillary Employees Stock Option Scheme-2021' (ESOP 2021). This ratification is a regulatory requirement under SEBI (SBEB & SE) Regulations following the company's listing on the stock exchanges. The scheme involves up to 72,91,000 options, each convertible into one equity share of face value ₹2. Shareholders can participate in the e-voting process from December 6, 2025, to January 4, 2026.
Key Highlights
Ratification of ESOP 2021 involving a total of 72,91,000 employee stock options.
Each option is exercisable into one equity share of face value ₹2 each.
E-voting period is scheduled from December 6, 2025, to January 4, 2026.
The scheme was previously approved by members on May 30, 2025, prior to the company's listing.
The resolution is proposed as a Special Resolution to comply with SEBI post-listing mandates.
👀 What to Watch
Investors should view this as a routine compliance matter for a newly listed company to maintain its talent retention programs. Note the potential equity dilution of approximately 7.29 million shares as options are exercised over time.
Capillary Technologies Amends Insider Trading Prohibition Code
Capillary Technologies India Limited has updated its Insider Trading Prohibition Code, as approved by the Board of Directors on December 4, 2025. The amended code, Version 2, is available on the company's website. This update ensures compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The code applies to all Insiders, including employees, directors, designated persons and connected persons.
Key Highlights
Board approved amendments to Insider Trading Prohibition Code on December 4, 2025
Amended Insider Trading Prohibition Code is Version 2
Original Insider Trading Prohibition Code was approved on November 6, 2025
Compliance Officer email: secretarial@capillarytech.com
Applicable to Designated Persons including employees up to two levels below the chief executive officer
👀 What to Watch
Investors should review the updated Insider Trading Prohibition Code on the company's website to understand their obligations. Monitor company announcements for further updates on corporate governance.
